Quanyin Hu, a professor in the UW-Madison School of Pharmacy, said the approach could theoretically be applied to any cancer ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

While research in mice has shown encouraging results, the next phases of human trials will need to confirm safety and ...

US researchers have found that developing personalised vaccines can play a key role in keeping aggressive tumours from ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

Transgene has completed the initial subject screening for the Phase II segment of its Phase I/II trial of vaccine, TG4050.

Together, they developed a vaccine that trains the immune system to recognize and attack pancreatic cancer cells. The vaccine ...

Researchers have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two ...

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing ...